ALLISON MATAVA: Open Payments
NPI 1790513091 · INDIANA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 28 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $70 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $138 |
| Ardelyx, Inc. | 4 | $99 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $66 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Novo Nordisk Inc | 2 | $37 |
| PFIZER INC. | 2 | $34 |
| Verona Pharma, Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
Products named: UBRELVY, IBSRELA, XIFAXAN, VOQUEZNA, QULIPTA, Ohtuvayre, AIRSUPRA, ELIQUIS.
Industry payments across PA — which companies pay providers there.
